AGOMAB THERAPEUTICS NV

Insider buying surge at AgomAb Therapeutics shows exec confidence amid a steep decline – a unique chance for value investors to gauge upside potential.

CEO of AGOMAB THERAPEUTICS buys shares amid stock slump, signaling confidence in pipeline and potential rebound—investors should watch upcoming trials.